CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026)
CRISPR Therapeutics AG's (CRSP) quarterly EPS (Basic) came in at -$0.94 in Q2 2026, up 60.55% year-over-year from -$0.59 in Q2 2025, and up 26.17% quarter-over-quarter from -$1.28 in Q1 2026.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has disclosed EPS (Basic) across 12 years of filings, most recently posting -$0.94 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 60.55% year-over-year to -$0.94; the TTM figure through Jun 2026 stood at -$5.01 (up 14.36% YoY), while the FY2025 annual figure was -$6.83, down 41.22% from the prior year.
- EPS (Basic) came in at -$0.94 for Q2 2026 at CRISPR Therapeutics AG, up from -$1.28 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.74 in Q4 2023 to a low of -$2.4 in Q2 2022.
- Average EPS (Basic) over 5 years is -$1.38, with a median of -$1.42 recorded in 2023.
- Year-over-year, EPS (Basic) surged 150.97% in 2023 and plunged 226.6% in 2024.
- Over 5 years, EPS (Basic) stood at -$1.45 in 2022, then surged by 150.97% to $0.74 in 2023, then sank by 226.6% to -$0.94 in 2024, then tumbled by 93.69% to -$1.81 in 2025, then surged by 47.92% to -$0.94 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.94 in Q2 2026, -$1.28 in Q1 2026, and -$1.81 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.19 Bn | 5.19 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -1.18 |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 0.04 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | -0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.94 |
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.81 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -2.40 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | -0.94 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.43 |
| Dec 31, 2023 | 0.74 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -1.45 |
| Sep 30, 2022 | -2.24 |
| Jun 30, 2022 | -2.40 |
| Mar 31, 2022 | -2.32 |
| Dec 31, 2021 | -1.86 |
| Sep 30, 2021 | -1.67 |